Publications by authors named "I J de Groot"

Although gold-based catalysts are promising candidates for selective low-temperature CO oxidation, the reaction mechanism is not fully understood. On a Au(111) model catalyst, we observe the formation of gold oxide islands under exposure to atmospheric pressures of oxygen or CO oxidation reaction conditions in an scanning tunneling microscope. The gold oxide formation is interpreted in line with the water-enabled dissociation of O on the step edges of Au(111).

View Article and Find Full Text PDF

The process of hydrodesulfurization is one of the most important heterogeneous catalytic reactions in industry as it helps with reducing global SO emissions by selectively removing the sulfur contaminants from commercial fuel. In this work, we successfully combine high-pressure scanning tunneling microscopy and reaction modeling using density functional theory to observe the hydrodesulfurization of methanethiol (CHSH) on the Co-substituted S edges of a Co-promoted MoS model catalyst in situ at near-industrial conditions and investigate the plausible reaction pathways. The active sites on the Co-substituted S edges show a time-varying atomic structure influenced by the hydrodesulfurization reaction rate.

View Article and Find Full Text PDF

Background: Validated patient-reported outcome measures to assess disease impact in patients with adult idiopathic inflammatory myopathies (IIMs) are needed. The objective of this study was to assess the construct validity of PROMIS Pain Interference, Fatigue, and Physical Function measures in comparison with core disease activity measures.

Methods: Adults with IIM, excluding inclusion body myositis, from OMERACT Myositis Working Group (MWG) clinic sites completed PROMIS Short Form v1.

View Article and Find Full Text PDF
Article Synopsis
  • Duchenne and Becker muscular dystrophy currently have no cure, but the Dutch Dystrophinopathy Database (DDD) aims to facilitate therapy development by gathering comprehensive and reusable data from affected patients.
  • DDD allows for online enrollment and participation at varying levels, collecting important clinical and self-reported data while maintaining a governance structure for effective management and oversight.
  • As of November 1, 2023, the database has 742 enrolled participants, enabling the identification of potential candidates for clinical studies and supporting ongoing research in the field.
View Article and Find Full Text PDF